Jennison Associates’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Jennison Associates’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-238,152	Closed	-$1.82M	–	769
2014 Q2	$1.82M	Hold	238,152	–	–	﹤0.01%	580
2014 Q1	$2.51M	Hold	238,152	–	–	﹤0.01%	567
2013 Q4	$3.09M	Hold	238,152	–	–	﹤0.01%	534
2013 Q3	$2.02M	Buy	238,152 +31,887	+15%	+$257K	﹤0.01%	562
2013 Q2	$1.16M	Buy	+206,265	New	+$1.28M	﹤0.01%	577

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAAMCP

Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return

Jennison Associates's OCRX Position: Q3 2014 in Review

Jennison Associates sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2014, closing a stake of 238,152 shares — an estimated $1.82M sold.

Jennison Associates first reported a position in OCRX in Q2 2013 and held it in 5 quarters. The position peaked at $3.09M in Q4 2013. 31 funds tracked by Wall St. Rank hold OCRX as of Q3 2014.

Jennison Associates reported no remaining Ocera Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
Jennison Associates sold 238,152 Ocera Therapeutics, Inc. shares in Q3 2014, an estimated $1.82M.
Jennison Associates first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 5 quarters.
Jennison Associates's Ocera Therapeutics, Inc. position peaked at $3.09M in Q4 2013.
31 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2014.

Based on Jennison Associates's 13F filing for Q3 2014, filed 5 Nov 2014.